AB Science - Company & Market Research Reports

AB Science is a pharmaceutical company specializing in the discovery, development, and commercialization of novel targeted therapies named protein kinase inhibitors. Their therapies treat diseases such as cancers, inflammatory diseases, and central nervous system diseases in both human and veterinary medicine. It serves hospitals and specialist physicians. The company was founded in 2001 and is headquartered in Paris, France.

Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

  • Report
  • 722 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

  • Report
  • 713 Pages
From
Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Alzheimer s: Epidemiology Overview and Insights - Product Thumbnail Image

Alzheimer s: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
Alzheimer's: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Alzheimer's: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
2018 Systemic Mastocytosis Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Systemic Mastocytosis Drug Development- Pipeline Analysis Report

  • Report
  • 40 Pages
From
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets - Product Thumbnail Image

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

  • Report
  • 144 Pages
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Report
  • 1051 Pages
From
Rheumatoid Arthritis - Pipeline Review, H1 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • Report
  • 1020 Pages
From
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market - Product Thumbnail Image

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • Report
  • 143 Pages
From
Alzheimer's Disease Therapeutics in Major Developed Markets to 2021 - Aging Population and Improved Disease Understanding Increase Demand for Disease Modifying Agents - Product Thumbnail Image

Alzheimer's Disease Therapeutics in Major Developed Markets to 2021 - Aging Population and Improved Disease Understanding Increase Demand for Disease Modifying Agents

  • Report
  • 144 Pages
From
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 203 Pages
From
Alzheimer's Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Disease Modifying Therapies - Product Thumbnail Image

Alzheimer's Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Disease Modifying Therapies

  • Report
  • 151 Pages
From
Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016 - Product Thumbnail Image

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • Report
  • 169 Pages
From
Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016 - Product Thumbnail Image

Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016

  • Report
  • 320 Pages
From
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant - Product Thumbnail Image

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • Report
  • 122 Pages
From
Global Malignant Melanoma Drug Market & Clinical Pipeline Insight - Product Thumbnail Image

Global Malignant Melanoma Drug Market & Clinical Pipeline Insight

  • Drug Pipelines
  • 500 Pages
From
Alzheimer's Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H1 2018

  • Report
  • 1203 Pages
From
PharmaPoint: Alzheimer s Disease - Global Drug Forecast and Market Analysis to 2026 - Product Thumbnail Image

PharmaPoint: Alzheimer s Disease - Global Drug Forecast and Market Analysis to 2026

  • Report
  • 330 Pages
From
Loading Indicator
adroll